Key result
Two months of ACE inhibition with oral Quinapril significantly decreased urinary excretion of both albumin (from 51 to 43 mg/24h, p=0.05) and tubular THGP (from 19 to 12 mg/24h, p=0.02).
Why the study?
Does oral quinapril reduce the urinary excretion of tubular proteins like Tamm-Horsfall Glycoprotein in essential hypertensives?
Observational (n=15)
Does oral quinapril reduce the urinary excretion of tubular proteins like Tamm-Horsfall Glycoprotein in essential hypertensives?
ACE inhibition with quinapril significantly decreases the urinary excretion of both albumin and the tubular protein THGP, suggesting an effect on renal tubular cells beyond just glomerular hemodynamics.
Answers are grounded in this paper and cite their sources.
May suggest quinapril affects tubular protein handling in hypertension; challenges glomerular-only mechanism and leaves open need for randomized confirmation.
It is believed that angiotensin converting-enzyme (ACE) inhibitors lower proteinuria by acting on glomerular hemodynamics. This hypothesis predicts that the urinary excretion of a tubular protein should be unaffected by ACE inhibition. In the present study we have compared the excretion of albumin and Tamm-Horsfall Glycoprotein (THGP), a protein secreted only by renal tubules, before and after ACE inhibition. Urinary protein excretion was measured with the Phast System, a method based on SDS polyacrylamide gel electrophoresis followed by silver staining, in 15 essential hypertensives, after at least 4 weeks of wash-out from any drug and after 2 months of ACE inhibition with oral Quinapril. After 2 months of ACE inhibition, blood pressure (BP), body weight, urinary output, heart rate, plasma glucose, plasma and urinary creatinine, urate and electrolytes, and creatinine clearance, were not different from baseline values. Plasma ACE activity decreased from 76 +/- 7 to 10 +/- 4 U/mL (mean +/- SEM, 2 tails paired t test, p = 0.0001). Both albumin and THP urinary excretions decreased from 51 +/- 6 to 43 +/- 4 mg/ 24 h (p = 0.05) and from 19 +/- 3 to 12 +/- 1 mg/24 h (p = 0.02), respectively. This unexpected result suggests that ACE inhibitors may act also at the level of renal tubular cells.
No takes yet. Share an insight, caveat, or question.
Guidi et al. (1998) conducted an observational in Essential hypertension (n=15). Oral Quinapril vs. Baseline was evaluated on Urinary excretion of albumin and Tamm-Horsfall Glycoprotein (THGP) (p=0.05 (albumin), 0.02 (THGP)). Two months of ACE inhibition with oral Quinapril significantly decreased urinary excretion of both albumin (from 51 to 43 mg/24h, p=0.05) and tubular THGP (from 19 to 12 mg/24h, p=0.02).
Synapse has enriched 10 related papers. Consider them for comparative context: